969 Pill - orange round, 6mm
Pill with imprint 969 is Orange, Round and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base). It is supplied by Sun Pharmaceutical Industries Inc.
Buprenorphine/naloxone is used in the treatment of Opioid Use Disorder and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 2 mg (base) / 0.5 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).
Images for 969
Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)
- Imprint
- 969
- Strength
- 2 mg (base) / 0.5 mg (base)
- Color
- Orange
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Narcotic analgesic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 3 - Moderate abuse potential
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 62756-0969
- Inactive Ingredients
-
lactose monohydrate,
mannitol,
povidone,
citric acid anhydrous,
sodium citrate,
FD&C Yellow No. 6,
butylated hydroxyanisole,
magnesium stearate,
acesulfame potassium,
corn starch
Note: Inactive ingredients may vary.
Related images for "969"
More about buprenorphine / naloxone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,131)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: narcotic analgesic combinations
- En español
Patient resources
- Buprenorphine and naloxone oral/sublingual drug information
- Buprenorphine/naloxone (Advanced Reading)
Other brands
Suboxone, Zubsolv, Bunavail, Cassipa
Professional resources
- Buprenorphine Buccal Film prescribing information
- Buprenorphine and Naloxone Sublingual Film (FDA)
- Buprenorphine and Naloxone Sublingual Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.